ArticleThe Journal of investigative dermatology2017
Melanoma Expression Genes Identified through Genome-Wide Association Study of Breslow Tumor Thickness.
Abstract readLetter
In one paragraph
Article in The Journal of investigative dermatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Germline variants are associated with increased primary melanoma tumor thickness at diagnosis.Human molecular genetics · 2021Article
- Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival.Molecular carcinogenesis · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Shenying FangDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: sfang@mdanderson.org.
Amaury VaysseINSERM, Genetic Variation and Human Diseases Unit, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France.
Myriam BrossardINSERM, Genetic Variation and Human Diseases Unit, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France.
Yuling WangDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Defeng DengDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Quan LiuDepartment of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Peter ZhangDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Kejing XuDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Ming LiDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Runhua FengDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Huey LiuDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Yifang DangDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Wei ChenDepartment of Clinical Applications and Support, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Victor PrietoDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jeffrey E GershenwaldDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Merrick I RossDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Brenna MatejkaDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Jared MalkeDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Lauren E HayduDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
John D ReveilleDivision of Rheumatology and Clinical Immunogenetics, The University of Texas Health Science Center, Houston, Texas, USA.
Dawen SuiDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Roland L BassettDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Nadya KoshkinaDepartment of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Marie Françoise AvrilAP-HP, Hôpital Cochin et Université Paris Descartes, Paris, France.
Mason LuDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Qingyi WeiDuke Cancer Institute, Duke University Medical Center and Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Florence DemenaisINSERM, Genetic Variation and Human Diseases Unit, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Institut Universitaire d'Hématologie, Paris, France.
Christopher I AmosDepartment of Community and Family Medicine, Geisel College of Medicine, Dartmouth College, Lebanon, New Hampshire, USA.
Jeffrey E LeeDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: jelee@mdanderson.org.
Funding
Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8MTranslational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3MUT M.D. Anderson Cancer Center SPORE in MelanomaP50CA093459 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GRIMM, ELIZABETH A · 2004 to 2014
$23.7MGenetic determinants of Breslow tumor thickness and their impact on melanoma progR03CA173792 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI FANG, SHENYING · 2013 to 2014
$156kNCI NIH HHS P30 CA016672NCI NIH HHS P30 CA023108NCI NIH HHS P50 CA093459NCI NIH HHS R03 CA173792
Abstract
PubMed holds no abstract for this paper.
Indexed as
Biomarkers, TumorDisease-Free SurvivalDNA-Binding ProteinsDNA Repair EnzymesFemaleFollow-Up StudiesGenome-Wide Association StudyHumansMaleMelanomaMucin 5ACPolymorphism, Single NucleotideProspective StudiesRisk FactorsSkinSkin NeoplasmsBiomarkers, TumorDNA-Binding ProteinsDNA Repair EnzymesMUC5AC protein, humanMucin 5ACRAD23A protein, human
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.